24/7 Market News Snapshot 30 May, 2025 – TIAN RUIXIANG Holdings Ltd Class A Ordinary Shares (NASDAQ:TIRX)

May 30, 2025

DENVER, Colo., 30 May, 2025 (www.247marketnews.com) – (Nasdaq:TIRX) are discussed in this article.
TIAN RUIXIANG Holdings Ltd (Nasdaq:TIRX) has recently experienced a noteworthy surge in its stock price, with shares soaring to $2.461, reflecting a substantial gain of 34.48% from the previous close of $1.830 during pre-market trading. This increase is accompanied by a vigorous trading volume of 2.09 million shares, indicating robust investor confidence and interest in the company’s future prospects.

The bullish trend coincides with TIAN RUIXIANG’s announcement regarding a strategic acquisition aimed at enhancing its market position in the health insurance sector. The company intends to acquire 100% of Ucare Inc., a prominent cloud-based platform specializing in AI-driven health insurance risk management, in an all-share deal valued at approximately $150 million. Under this agreement, the key shareholders of Ucare will receive around 101.5 million newly issued class A ordinary shares of TRX, constituting about 91.75% of the total issued shares post-closing.

This acquisition positions TIAN RUIXIANG to leverage Ucare’s advanced technological capabilities, which play a pivotal role in reducing healthcare fraud, waste, and administrative costs. Serving over 4,000 hospitals, Ucare has been instrumental in achieving an estimated US$6.82 billion in healthcare expenditure reductions. The company demonstrated fiscal strength with a net profit of US$0.6 million on revenues of US$5.4 million for the year ending October 31, 2024.

Sheng Xu, Chairwoman and CEO of TRX, underscored the significance of this acquisition, stating that integrating Ucare’s AI solutions will advance the company’s objectives and enhance its offerings in the insurance market. Following the expected completion of the transaction by July 2025, Ucare will function as a wholly-owned subsidiary of TRX’s VitaCare Limited, with its management team, including CEO Mr. Wei Zhu, remaining intact to facilitate continued growth.

This strategic initiative, coupled with the recent stock performance, suggests a promising outlook for TIAN RUIXIANG as it endeavors to redefine health insurance solutions in an evolving marketplace.

Related news for (TIRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.